The Phylum Bryozoa: From Biology to Biomedical Potential

Area of Science:

• Marine Biology
• Natural Product Chemistry
• Medicinal Chemistry

Background:

• The phylum Bryozoa remains an under-explored source of marine natural products, with less than 1% characterized since 1963.
• Bryozoans possess sophisticated chemical defenses, representing a vast reservoir of potentially bioactive metabolites.

Purpose of the Study:

• To review the chemoecology of bryozoans and highlight their potential medicinal applications.
• To focus on bryozoan metabolites for treating viral, brain, and parasitic diseases.
• To evaluate synthetic and biotechnological approaches for sustainable metabolite production.

Main Methods:

• Literature review of chemoecological data on bryozoans.
• Analysis of known bryozoan metabolites and their bioactivities.
• Discussion of synthetic strategies and biotechnological potential.

Main Results:

• Bryozoans offer a rich source of unique chemical structures with potential therapeutic benefits.
• Metabolites from bryozoans show promise against viral, neurological, and parasitic infections.
• Challenges and opportunities exist in both total synthesis and biotechnological production.

Conclusions:

• Bryozoans represent a significant, underexplored resource for drug discovery.
• Further research into bryozoan metabolites could yield novel treatments for various human diseases.
• Sustainable production methods are crucial for realizing the therapeutic potential of these compounds.